Unlike current Alzheimer medications, this one is not designed to improve symptoms but to get to the plaque in the brain that develops in Alzheimer's patients and stop the destruction. Specifically, the pill targets a compound in the brain called the Amyloid Peptide.
"The results are quite encouraging. The result of the phase two study do show that this drug is safe and effective. That is, it reduces Amyloid levels in the cerebral spinal fluid," says Dr. Paul Aisen, researcher.
The only two testing sites in Texas are in Houston and San Antonio. This final phase of the study will continue through the end of next year.
For more information on the Alzhemed study, call 1-877-680-4500.